91ÑÇÉ«´«Ã½

Journal News

JLR: Finding the structure of a lipid that keeps our tears clear

Laurel Oldach
Sept. 1, 2018

Because humans evolved from the sea, we carry a little of it with us to stay alive. Salt water makes up the cytoplasm in our cells, the plasma in our blood and the tears in our eyes.

This image by first author Sarah Hancock shows an iris surrounded by the lipid she and colleagues in the Blanksby and Mitchell labs characterized by mass spectronomy.Journal of Lipid Research

But water alone isn’t enough to keep the eye from drying out. A microscopically thin film of oils known as the lipid layer protects the tear film from evaporating. In the August issue of the Journal of Lipid Research, the structure of a key long-chain lipid in this layer. Their finding may be used to improve treatments for dry eye.

Although the long-chain lipids in question make up just 5 percent of the tear-film lipid layer, they play an important role in vision. Without them, earlier studies showed, the lipid layer would resemble an oil slick atop a puddle.

“This clearly wouldn’t be satisfactory for you to look through,” said , a professor at the Queensland University of Technology who led the research team in this study.

Blanksby saw the earlier research in Langmuir troughs carried out by others as a prompt to determine the precise structure of the ultra-long-chain lipids of the eye.

The tear-film lipid layer comes from meibum secreted by the lower eyelid. Scientists can collect meibum samples from brave volunteers by running a small spatula gently over their lower lids, but it is difficult to obtain enough for conventional assays like nuclear magnetic resonance spectroscopy.

Complicating matters, the team needed to differentiate between isomers. They knew the long lipids were made of two fatty acids but not whether they were joined end-to-end or branched, a question conventional mass spectrometry couldn’t answer.

Fortunately, Blanksby and colleague of the University of Wollongong have spent the last decade fine-tuning mass spectrometric techniques to characterize lipids.

“We were able to bring a unique toolbox to bear,” said Blanksby. “Some of these techniques may not exist outside Todd’s and my laboratory.”

By incorporating established approaches, such as ozonolysis, into a mass spectrometry workflow, the team determined that the most abundant of the ultra-long lipids is joined end-to-end, and they pinpointed each of its double bonds. The mass spectrometrists handed off the structure to chemist colleagues led by Michael Kelso, who developed a method to synthesize it.

The team now is working with industry partner Allergan, which cofunded the research with the Australian Research Council, on incorporating the new synthetic long-chain lipid as a component of drops for dry eye. While our knowledge of the lipid layer has expanded, according to Blanksby many eye drops still use mineral oil.

“This type of work provides a framework to produce a product that mimics, and is based on, the actual components that are present in human tears,” he said.

Blanksby hopes that by creating a better match to the real tear film, blurriness and other side effects of using eye drops can be alleviated.

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the 91ÑÇÉ«´«Ã½.

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Exploring lipid metabolism: A journey through time and innovation
91ÑÇÉ«´«Ã½ Annual Meeting

Exploring lipid metabolism: A journey through time and innovation

April 4, 2025

Recent lipid metabolism research has unveiled critical insights into lipid–protein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the 91ÑÇÉ«´«Ã½ annual meeting.

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025
91ÑÇÉ«´«Ã½ Annual Meeting

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025

April 2, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.

 A new kind of stem cell is revolutionizing regenerative medicine
Feature

A new kind of stem cell is revolutionizing regenerative medicine

April 1, 2025

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
91ÑÇÉ«´«Ã½ Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an 91ÑÇÉ«´«Ã½ Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
91ÑÇÉ«´«Ã½ Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.